1.08
price down icon2.70%   -0.03
pre-market  Vorhandelsmarkt:  1.16   0.08   +7.41%
loading

Renovorx Inc Aktie (RNXT) Neueste Nachrichten

pulisher
Oct 13, 2025

RenovoRx : Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD - MarketScreener

Oct 13, 2025
pulisher
Oct 13, 2025

Is RenovoRx Inc. stock entering bullish territory2025 Stock Rankings & Community Trade Idea Sharing Platform - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is RenovoRx Inc. reversing from oversold territoryJuly 2025 Snapshot & Free High Accuracy Swing Entry Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Identifying reversal signals in RenovoRx Inc.Weekly Investment Report & Free Growth Oriented Trading Recommendations - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

RenovoRx Inc. stock chart pattern explainedMarket Weekly Review & Step-by-Step Trade Execution Guides - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Relative strength of RenovoRx Inc. in sector analysisJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

What does recent volatility data suggest for RenovoRx Inc.Trade Entry Summary & Breakout Confirmation Trade Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is RenovoRx Inc. forming a bottoming baseEarnings Growth Summary & Weekly Chart Analysis and Guides - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will RenovoRx Inc. stock outperform Dow Jones indexAnalyst Upgrade & Risk Controlled Daily Trade Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

RenovoRx adds interventional oncology expert to scientific advisory board By Investing.com - Investing.com Nigeria

Oct 09, 2025
pulisher
Oct 09, 2025

RenovoRx’s Earnings Call: Positive Outlook Amid Growth - MSN

Oct 09, 2025
pulisher
Oct 09, 2025

RenovoRx adds interventional oncology expert to scientific advisory board - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

RenovoRx Appoints Renowned Oncologist Thierry de Baère, MD, PhD, to Scientific Advisory Board - Quiver Quantitative

Oct 09, 2025
pulisher
Oct 09, 2025

400+ publications & 22,000 citations: RenovoRx appoints Thierry de Baère to Scientific Advisory Board - Stock Titan

Oct 09, 2025
pulisher
Oct 09, 2025

Will RenovoRx Inc. outperform the marketMarket Weekly Review & Intraday High Probability Setup Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will earnings trigger a reversal in RenovoRx Inc.Buy Signal & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Forecasting RenovoRx Inc. price range with options data2025 Investor Takeaways & Weekly Momentum Picks - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is RenovoRx Inc. stock reversal real or fake2025 Short Interest & Real-Time Volume Triggers - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

RenovoRx : Corporate Overview - MarketScreener

Oct 07, 2025
pulisher
Oct 06, 2025

Custom strategy builders for tracking RenovoRx Inc.2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Developing predictive dashboards with RenovoRx Inc. dataEarnings Overview Report & Long-Term Growth Portfolio Plans - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How institutional ownership impacts RenovoRx Inc. stock2025 Short Interest & Fast Gaining Stock Reports - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

RenovoRx prices public offering to raise $12.1M - MSN

Oct 03, 2025
pulisher
Oct 03, 2025

Comparing Annovis Bio (NYSE:ANVS) & RenovoRx (NASDAQ:RNXT) - Defense World

Oct 03, 2025
pulisher
Oct 01, 2025

RenovoRx (NASDAQ:RNXT) Trading Up 7.6% – Here’s What Happened - Defense World

Oct 01, 2025
pulisher
Sep 30, 2025

What analysts say about RenovoRx Inc stockCurrency Fluctuation Impact & Register for the Next Free Workshop - earlytimes.in

Sep 30, 2025
pulisher
Sep 30, 2025

RenovoRx Inc Stock Analysis and ForecastTechnical Pattern Recognition & Budget Friendly Portfolio Growth - earlytimes.in

Sep 30, 2025
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):